Yazar "0000-0002-9278-6703" için listeleme
-
Assessment of Patients with von Willebrand Disease with ISTH/BAT and PBQ Scores
Apak, Fatma Burcu Belen; Umit, Elif Gulsum; Zengin, Yagmur; Evim, Melike Sezgin; Unal, Ekrem; Ozbas, Hasan Mucahit; Acipayam, Can (2020) -
Can Hepatitis A Vaccine Provide Protection Against COVID-19?
Sarialioglu, Faik; Apak, Fatma Burcu Belen; Haberal, Mehmet (2020) -
Hepatitis A susceptibility parallels high COVID-19 mortality
Sarialioglu, Faik; Belen, Fatma Burcu; Hayran, Kadir Mutlu (2021)Background/aim: COVID-19 has become the biggest health problem of this century. It has been hypothesized that immunity against hepatitis A virus (HAV) may provide protection from COVID19. Materials and methods: As of ... -
The old but new: Can unfractioned heparin and low molecular weight heparins inhibit proteolytic activation and cellular internalization of SARS-CoV2 by inhibition of host cell proteases?
Belen-Apak, F. B.; Sarialioglu, F. (2020)Currently, our world is facing the 2019 Novel Coronavirus (COVID-19) outbreak and tremendous efforts are made for developing drugs to treat and vaccines to prevent the disease. At present, there is no specific antiviral ... -
Promising Drug Fondaparinux for the Treatment of COVID-19: an In Silico Analysis of Low Molecular Weight Heparin, Direct Oral Anticoagulant, and Antiplatelet Drug Interactions with Host Protease Furin
Ertan-Bolelli, Tugba; Bolelli, Kayhan; Elci, Sitki Doga; Belen-Apak, F. Burcu (2022)Purpose As of July 2022, the COVID-19 pandemic has affected over 555 million worldwide confirmed cases and caused more than 6.3 million deaths. The studies showed that the D-dimer levels were increased in non-survivors ... -
Pulmonary intravascular coagulation in COVID-19: possible pathogenesis and recommendations on anticoagulant/thrombolytic therapy
Belen-Apak, F. Burcu; Sarialioglu, F. (2020)